Nature Reviews Clinical Oncology
Vol. 22, Issue 11
Issue 11
2025
9
Articles
Articles in this Issue
ALASCCA: an aspirin a day keeps colorectal cancer away
David Killock
Nov 01, 2025
pp. 801-801
10.1038/s41571-025-01082-2
MARIPOSA demonstrates overall survival benefit from amivantamab–lazertinib
Diana Romero
Nov 01, 2025
pp. 801-801
10.1038/s41571-025-01081-3
Maintenance tarlatamab extends overall survival
Peter Sidaway
Nov 01, 2025
pp. 801-801
10.1038/s41571-025-01078-y
The molecular blueprint of targeted radionuclide therapy
Irina Primac, Kevin Tabury, Alpaslan Tasdogan et al.
Nov 01, 2025
pp. 869-894
10.1038/s41571-025-01069-z
Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine
Philippe Lambin, Henry C. Woodruff, Shruti Atul Mali et al.
Nov 01, 2025
pp. 831-846
10.1038/s41571-025-01067-1
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia
Antonino Glaviano, Ellen Weisberg, Hiu Y. Lam et al.
Nov 01, 2025
pp. 847-868
10.1038/s41571-025-01068-0
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
Martin Reck, Nikolaj Frost, Solange Peters et al.
Nov 01, 2025
pp. 806-830
10.1038/s41571-025-01061-7
SERENA-6: dynamic ctDNA assessment and the future of precision cancer medicine
Arielle J. Medford, Seth A. Wander
Nov 01, 2025
pp. 804-805
10.1038/s41571-025-01066-2
Surprising role of CMV in shaping outcomes of immunotherapy for melanoma — chronic infection yields favourable survival
Anthony R. Cillo, John M. Kirkwood
Nov 01, 2025
pp. 802-803
10.1038/s41571-025-01065-3
All Issues
Journal Info
Publisher
Springer Science and Business Media LLC
ISSN
1759-4774
E-ISSN
1759-4782
Subject
Medicine
Language
English